MENS vs MGTX

Jyong Biotech Ltd. vs MeiraGTx Holdings plc — Valuation Comparison 2026

MENS

Biotechnology
Jyong Biotech Ltd.
Quality
2.3
out of 10
Value Trap
Price
$2.25
Last close
Models
9/13
Active
VS

MGTX

Biotechnology
MeiraGTx Holdings plc
Quality
5.3
out of 10
Value Trap
18
SAFE
Price
$10.00
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType MENS Fair ValueMENS Upside MGTX Fair ValueMGTX Upside
Bayesian DCF Intrinsic $0.60 -73.5% $2.59 -74.1%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.44 -33.4% $0.22 -97.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $0.17 -92.1% $9.14 -5.8%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for MENS vs MGTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MENS vs MGTX — Which Stock Is More Undervalued?

MGTX scores higher with a 5.3/10 quality rating vs MENS's 2.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Jyong Biotech Ltd. (MENS) and MeiraGTx Holdings plc (MGTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MENS currently trades at $2.25 with a QOC of 2.3/10, while MGTX trades at $10.00 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).